In the era of the HPV vaccine, what are the current HPV subtypes contributing to high-grade cervical dysplasia, adenocarcinoma in situ, and early cervical cancer?

被引：0
|
作者：
Covens, Allan [1 ]
Gien, Lilian [1 ]
Vicus, Danielle [1 ]
Shier, Michael [1 ]
Kupets, Rachel [1 ]
Gibbons, Suzanne [2 ]
Severini, Alberto [2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Publ Hlth Agcy Canada, Winnipeg, MB, Canada
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2313
引用
收藏
页码：S409 / S409
页数：1
相关论文
共 50 条
  • [1] What Are the Current HPV Types Contributing to Cervical High-Grade Squamous Intraepithelial Lesions, Adenocarcinoma In Situ, and Early Cervical Cancer?
    Salman, Lina
    Gien, Lilian T.
    Vicus, Danielle
    Shier, Michael
    Kupets, Rachel
    Gibbons, Suzanne
    Ashfaq, Samar
    Severini, Alberto
    Covens, Allan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2025, 47 (03)
  • [2] HPV Vaccination and Its Influence on HPV Detection in Women with High-Grade Cervical Dysplasia
    Cullum, R.
    Lucic, D.
    Schmidt, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S67 - S68
  • [3] Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal
    Pista, Angela
    de Oliveira, Carlos Freire
    Lopes, Carlos
    Cunha, Maria J.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2017, 139 (01) : 90 - 94
  • [4] Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
    Giannini, Andrea
    Di Donato, Violante
    Sopracordevole, Francesco
    Ciavattini, Andrea
    Ghelardi, Alessandro
    Vizza, Enrico
    D'Oria, Ottavia
    Simoncini, Tommaso
    Plotti, Francesco
    Casarin, Jvan
    D'Auge, Tullio Golia
    Cuccu, Ilaria
    Serati, Maurizio
    Pinelli, Ciro
    Bergamini, Alice
    Gardella, Barbara
    Dell'Acqua, Andrea
    Monti, Ermelinda
    Vercellini, Paolo
    D'Ippolito, Giovanni
    Aguzzoli, Lorenzo
    Mandato, Vincenzo Dario
    Giannella, Luca
    Scaffa, Cono
    Ditto, Antonino
    Falcone, Francesca
    Borghi, Chiara
    Malzoni, Mario
    Di Giovanni, Alessandra
    Salerno, Maria Giovanna
    Liberale, Viola
    Contino, Biagio
    Donfrancesco, Cristina
    Desiato, Michele
    Perrone, Anna Myriam
    De Iaco, Pierandrea
    Ferrero, Simone
    Sarpietro, Giuseppe
    Matarazzo, Maria G.
    Cianci, Antonio
    Cianci, Stefano
    Bosio, Sara
    Ruisi, Simona
    Mosca, Lavinia
    Tinelli, Raffaele
    De Vincenzo, Rosa
    Zannoni, Gian Franco
    Ferrandina, Gabriella
    Petrillo, Marco
    Capobianco, Giampiero
    VACCINES, 2023, 11 (03)
  • [5] Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer
    Ge, Yimin
    Christensen, Paul
    Luna, Eric
    Armylagos, Donna
    Schwartz, Mary R.
    Mody, Dina R.
    CANCER CYTOPATHOLOGY, 2017, 125 (08) : 652 - 657
  • [6] Prevention strategies of cervical cancer in the HPV vaccine era
    Bosch, Xavier
    Harper, Diane
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 21 - 24
  • [7] Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening
    Peace, Stephanie M.
    Jennings, Ashley J.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (01) : 87 - 93
  • [8] Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening
    Stephanie M. Peace
    Ashley J. Jennings
    Archives of Gynecology and Obstetrics, 2022, 305 : 87 - 93
  • [9] HPV positive and high grade cervical dysplasia: watching the trend
    Elliot, J.
    Sumner, D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 : 256 - 257
  • [10] HPV persistence after cervical surgical excision of high-grade cervical lesions
    Bogani, Giorgio
    Sopracordevole, Francesco
    Ciavattini, Andrea
    Vizza, Enrico
    Vercellini, Paolo
    Ghezzi, Fabio
    Scambia, Giovanni
    Di Donato, Violante
    Giannini, Andrea
    Raspagliesi, Francesco
    CANCER CYTOPATHOLOGY, 2024, 132 (05) : 268 - 269
12345